Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects with Renal Impairment

BACKGROUND: Semaglutide, a glucagon-like peptide-1 (GLP-1) analogue, has been co-formulated with the absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) caprylate (SNAC) as a tablet for oral administration. This trial (NCT02014259) investigated the pharmacokinetics, safety and tolerability of...

Descripción completa

Detalles Bibliográficos
Autores principales: Granhall, Charlotte, Søndergaard, Flemming L., Thomsen, Mette, Anderson, Thomas W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267549/
https://www.ncbi.nlm.nih.gov/pubmed/29623579
http://dx.doi.org/10.1007/s40262-018-0649-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267549/
https://www.ncbi.nlm.nih.gov/pubmed/29623579
http://dx.doi.org/10.1007/s40262-018-0649-2

Ejemplares similares